Johns Hopkins University, in association with the Realm of Caring Foundation, conducted research to study the effects of cannabis on depression and anxiety.
The peer-reviewed journal, Frontiers In Psychiatry, published the paper. According to the study, using medicinal cannabis led to lower self-reported depression, as well as decreased anxiety.
The Study Had Nearly 600 Participants, But They Were Not Diverse
The research team held an observational study that included 538 participants over the age of 18. These adults completed surveys regarding cannabis use and associated symptoms.
It’s important to note that the study was not universal. The group was majority Caucasian female adults.
To properly understand how cannabinoids affect everyone, further studies are needed.
Photo by CRYSTALWEED cannabis on Unsplash
Everyone in the Study Had Some Form of Anxiety or Depression
All participants included in the study had reported having anxiety or depression disorders, including major depressive disorder, postpartum depression, dysthymia, premenstrual dysphoric disorder, seasonal affective disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, or agoraphobia.
368 participants were currently using medical marijuana, while the remaining 170 participants were still considering it. The latter group was the control group.
The study analyzed cannabis use by product type (dried flower, hemp extract oil, etc.), chemotype (THC-dominant, CBD-dominant, and balanced THC:CBD ratio), dosing regimen, and mode of administration.
Photo by pariwat pannium on Unsplash
The Research Determined That Cannabis Could Have Therapeutics Uses
Furthermore, it concluded that “medicinal cannabis use was associated with lower self-reported depression.”
In addition, the participants who began using medicinal marijuana after the study reported decreased anxiety and depressive symptoms. The patients who didn’t use medical marijuana after didn’t report a change in their depressive or anxiety symptoms.
According to the study, medicinal cannabis users report better sleep, quality of life, and less pain on average.
However, the study only relied on self-reported data. Placebo-controlled studies will also be necessary to confirm these results. Further studies are required to determine the route of administration, dose, and product formulation characteristics to optimize clinical outcomes.
More Content
THE RELATIONSHIP BETWEEN BACKWOODS AND HIP-HOP
TERPENES FOR ANXIETY: 3 TERPS IN CANNABIS WITH STRESS-RELIEVING PROPERTIES
RAPPER WEED: WHICH RAPPERS HAVE CANNABIS PRODUCTS IN THE MARKET? WHO ACTUALLY HAS THE FIRE?
18 COMPANIES THAT DON’T DRUG TEST THEIR EMPLOYEES FOR WEED
7 TIPS FOR MARKETING CANNABIS AND CBD ON TIKTOK AND INSTAGRAM
